Skip to content

SOLIGENIX, INC.: 10-Q filed 2023-11-13

What SOLIGENIX, INC. reported in its quarterly report filed 2023-11-13 (fiscal Q3 2023): 41 published measures, 117 facts as tagged in accession 0001558370-23-018818.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-13
Fiscal period
fiscal Q3 2023
Accession
0001558370-23-018818 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SOLIGENIX, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-3011,302,829USD
At 2022-12-3114,279,717USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-307,081,674USD
At 2022-12-3116,750,500USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-304,221,155USD
At 2023-06-305,800,200USD
At 2022-12-31-2,470,826USD
At 2022-09-301,032,002USD
At 2022-06-304,205,886USD
At 2021-12-3110,722,598USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,662,702USD92
2023-01-01 to 2023-09-30-4,320,835USD273
2022-07-01 to 2022-09-30-3,309,003USD92
2022-01-01 to 2022-09-30-10,044,784USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-6,775,896USD273
2022-01-01 to 2022-09-30-9,021,880USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-30130,440USD92
2023-01-01 to 2023-09-30594,547USD273
2022-07-01 to 2022-09-30166,140USD92
2022-01-01 to 2022-09-30582,843USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-303,709,688USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-13,073USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-223,884,281USD
At 2022-12-31-219,563,446USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-3010,379,854shares92
2023-01-01 to 2023-09-306,874,493shares273
2022-07-01 to 2022-09-302,872,262shares92
2022-01-01 to 2022-09-302,867,076shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-3010,379,854shares92
2023-01-01 to 2023-09-306,874,493shares273
2022-07-01 to 2022-09-302,872,262shares92
2022-01-01 to 2022-09-302,867,076shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.16USD/shares92
2023-01-01 to 2023-09-30-0.63USD/shares273
2022-07-01 to 2022-09-30-1.15USD/shares92
2022-01-01 to 2022-09-30-3.5USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-0.16USD/shares92
2023-01-01 to 2023-09-30-0.63USD/shares273
2022-07-01 to 2022-09-30-1.15USD/shares92
2022-01-01 to 2022-09-30-3.5USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-1,161,197USD273
2022-01-01 to 2022-09-30-1,154,935USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-3013,517USD
At 2022-12-3118,481USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2023-09-3065,400USD92
2023-01-01 to 2023-09-30229,076USD273
2022-07-01 to 2022-09-3070,715USD92
2022-01-01 to 2022-09-30220,656USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,779,056USD92
2023-01-01 to 2023-09-30-5,560,069USD273
2022-07-01 to 2022-09-30-3,081,244USD92
2022-01-01 to 2022-09-30-10,668,926USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-3010,971,875USD
At 2022-12-3113,853,152USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-305,521,553USD
At 2022-12-3116,516,873USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-301,460,715USD
At 2022-12-313,865,796USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-301,799,055USD92
2023-01-01 to 2023-09-305,634,114USD273
2022-07-01 to 2022-09-303,117,944USD92
2022-01-01 to 2022-09-3010,836,812USD273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-3019,999USD92
2023-01-01 to 2023-09-3074,045USD273
2022-07-01 to 2022-09-3036,700USD92
2022-01-01 to 2022-09-30167,886USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-30110,441USD92
2023-01-01 to 2023-09-30520,502USD273
2022-07-01 to 2022-09-30129,440USD92
2022-01-01 to 2022-09-30414,957USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-30826,015USD92
2023-01-01 to 2023-09-302,535,165USD273
2022-07-01 to 2022-09-301,791,695USD92
2022-01-01 to 2022-09-305,586,302USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-3010,378,238shares
At 2022-12-312,908,578shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-09-3010,298,534USD
At 2022-12-3113,359,615USD
At 2022-09-3016,865,642USD
At 2021-12-3126,043,897USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-30228,070,740USD
At 2022-12-31217,064,964USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-09-3024,318USD
At 2022-12-3124,747USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-30258,487USD
At 2022-12-31340,987USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2023-09-301,416,463USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-09-30119,730USD
At 2022-12-31114,766USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-09-302,386,836USD
At 2022-12-312,307,746USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,662,702USD92
2023-01-01 to 2023-09-30-5,482,032USD273
2022-07-01 to 2022-09-30-3,309,003USD92
2022-01-01 to 2022-09-30-11,199,719USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-4,320,835USD273
2022-01-01 to 2022-09-30-10,044,784USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,644,445USD92
2023-01-01 to 2023-09-30-4,321,264USD273
2022-07-01 to 2022-09-30-3,294,600USD92
2022-01-01 to 2022-09-30-10,061,254USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-1,662,702USD92
2023-01-01 to 2023-09-30-4,320,835USD273
2022-07-01 to 2022-09-30-3,309,003USD92
2022-01-01 to 2022-09-30-10,044,784USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30973,040USD92
2023-01-01 to 2023-09-303,098,949USD273
2022-07-01 to 2022-09-301,326,249USD92
2022-01-01 to 2022-09-305,250,510USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-01-01 to 2023-09-3043,223USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30116,354USD92
2023-01-01 to 2023-09-3078,037USD273
2022-07-01 to 2022-09-30-227,759USD92
2022-01-01 to 2022-09-30-530,793USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-30488,011USD273
2022-01-01 to 2022-09-30643,921USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2023-01-01 to 2023-09-3080,458USD273

Inspect the source

Entity
SOLIGENIX, INC. / CIK 0000812796
Captured
2026-09-19T15:06:29.331Z
SEC response SHA-256
8629fd5cf775c1125cd5ba8089602df0d09016eba95e768aec70a78328c796d0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000812796.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))